**Correction to: BMC Nephrology (2019) 20:40**
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Following publication of the original article \[[@CR1]\], it was reported that Fig. [1i](#Fig1){ref-type="fig"} and Fig. [1j](#Fig1){ref-type="fig"} were omitted due to a typesetting mistake. In this Correction, the complete Fig. [1](#Fig1){ref-type="fig"} is shown and the original publication of this article has been updated to correct this. The publisher apologises to the authors and readers for the inconvenience.Fig. 1Box plots showing the postoperative course of the absolute (**a**/**c**/**e**/**g**/**i**) and relative (**b**/**d**/**f**/**h**/**j**) change (%) in eGFR at measurement times A-E for (**a**/**b**) the overall NSS cohort (NSS-C), (**c**/**d**) the NSS group with intraoperative renal ischaemia (NSS-RI) and without intraoperative renal ischaemia (NSS-NRI), (**e**/**f**) the LNSS group with intraoperative renal ischaemia (LNSS-RI), the ONSS group with intraoperative renal ischaemia (ONSS-RI), (**g**/**h**) the NSS group with postoperative AKI (NSS-AKI), the NSS group without postoperative AKI (NSS-NAKI), and (**i**/**j**) NSS group with a baseline eGFR category G1 (NSS-G1), NSS group with a baseline eGFR category G2 (NSS-G2), and NSS group with a baseline eGFR category ≥G3 (NSS ≥ G3). Definition of measurement times **a**-**e**: (**a**) highest change in eGFR from baseline during the planned hospital stay at a median of 1 day postoperatively (IQR, 1--2), (**b**) change in eGFR from baseline prior to discharge from hospital at a median of 4 days postoperatively (IQR, 2--6), (**c**) change in eGFR from baseline at a median of 47 days postoperatively (IQR, 30--105), (**d**) a median of 13 months postoperatively (IQR, 12--15), and (**e**) a median of 50 months postoperatively (IQR, 35--81). Asterisks indicate significant changes from baseline in the level of absolute and relative changes in eGFR over the course of the observation period (Friedman's test as a post hoc pairwise multiple comparison test) or between the compared groups at each measurement time (non-parametric Mann-Whitney U test). \* *p* \< 0.05, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001, (ns) not significant. eGFR, estimated glomerular filtration rate; NSS, nephron-sparing surgery; LNSS, laparoscopic nephron-sparing surgery; ONSS, open nephronsparing surgery; AKI, acute kidney injury; IQR, interquartile range

Additionally, the authors reported that the caption of Table [4](#Tab4){ref-type="table"} was incorrectly presented as "Multiple linear regression analysis". The correct presentation of this table caption is "Multiple regression analysis". And Table [4](#Tab4){ref-type="table"} with its corrected caption can be found on page 3-4.Table 4Multiple regression analysisa (model 1)Regression\
coefficient\
βMultiple linear regression\
95% CI*p*-valueBaseline eGFR (mL/ml/1.73 m^22^)- 0.20- 0.38 - − 0.020.03Baseline Haemoglobin (mg/dL)0.51- 0.86 - 1.890.46Tumour diameter (cm)0.67- 0.43 - 1.760.24Tumour locus central (ref.) vs. peripheral0.43- 3.80 - 4.670.84Surgical approach LNSS (ref.) vs. ONSS- 13.48- 17.65 - − 9.32\< 0.001Sex male (ref.) vs. female- 3.28- 7.80 - 1.250.16Age (years)- 0.17- 0.36 - 0.010.06BMI (kg/m^2^)- 0.88- 1.36 - − 0.41\< 0.001Hypertension no (ref.) vs. yes- 0.78- 4.75 - 3.180.70Ischaemia time (min)- 0.27- 0.41 - − 0.13\< 0.001Operative time (min)- 0.06- 0.09 - − 0.03\< 0.001Preoperative ureter stenting no (ref.) vs. yes- 0.46- 5.64 - 4.710.86Intraoperative blood transfusions no (ref.) vs. yes- 3.29- 11.91 - 5.330.45Postoperative complications no (ref.) vs. yes- 3.36- 8.42 - 1.700.19Clavien-Dindo score \< 3 (ref.) vs. ≥ 3- 10.98- 18.47 - − 3.480.004b (model 2)Regression\
coefficient\
βMultiple linear regression\
95% CI*p*-valueBaseline eGFR (mL/ml/1.73 m^22^)- 0.29- 0.49 - − 0.090.005Baseline Haemoglobin (mg/dL)- 0.32- 1.95 - 1.310.70Relative change of eGFR from baseline at time A (%)0.180.03 - 0.330.02AKI 48 h p.o. no (ref.) vs. yes- 2.11- 9.01 - 4.790.55Tumour diameter (cm)- 1.76- 2.87 - − 0.660.002Tumour locus central (ref.) vs. peripheral- 0.30- 5.14 - 4.540.90Surgical approach LNSS (ref.) vs. ONSS1.13- 4.17 - − 6.440.67Sex male (ref.) vs. female1.63- 3.43 - 6.700.53Age (years)- 0.10- 0.33 - 0.130.40BMI (kg/m2)0.15- 0.39 - 0.700.58Hypertension no (ref.) vs. yes- 2.11- 6.82 - 2.600.38Ischaemia time (min)0.03- 0.14 - 0.210.72Operative time (min)0.01- 0.03 - 0.050.54Preoperative ureter stenting no (ref.) vs. yes- 4.35- 10.46 - 1.770.16Intraoperative blood transfusions no (ref.) vs. yes4.12- 6.29 - 14.520.44Postoperative complications no (ref.) vs. yes1.20- 4.77 - 7.180.69Clavien-Dindo score \< 3 (ref.) vs. ≥ 34.43- 4.28 - 13.140.32c (model 3)ORMultiple logistic regression\
95% CI*p*-valueBaseline eGFR (mL/ml/1.73 m^22^)0.990.96 - 1.010.30Baseline Haemoglobin (mg/dl)0.850.70 - 1.030.10Tumour diameter (cm)0.940.81 - 1.080.35Tumour locus central (ref.) vs. peripheral1.200.70 - 2.050.51Surgical approach LNSS (ref.) vs. ONSS3.872.17 - 6.92\< 0.001Sex male (ref.) vs. female2.511.35 - 4.670.004Age (years)1.010.99 - 1.040.26BMI (kg/m^2^)1.131.06 - 1.21\< 0.001Hypertension no (ref.) vs. yes1.050.63 - 1.740.85Ischaemia time (min)1.021.00 - 1.040.046Operative time (min)1.011.00 - 1.010.002Preoperative ureter stenting no (ref.) vs. yes0.920.46 - 1.830.81Intraoperative blood transfusions no (ref.) vs. yes0.730.22 - 2.450.61Postoperative complications no (ref.) vs. yes1.790.92 - 3.480.08Clavien-Dindo score \< 3 (ref.) vs. ≥ 32.140.68 - 6.720.19d (model 4)ORMultiple logistic regression\
95% CI*p*-valueBaseline eGFR (mL/ml/1.73 m^2^)0.890.85 - 0.92\< 0.001Baseline Haemoglobin (mg/dL)0.990.73 - 1.350.95Relative change of eGFR from baseline at time A (%)0.980.98 - 1.010.12AKI 48 h p.o. no (ref.) vs. yes1.230.39 - 3.850.72Tumour diameter (cm)0.930.71 - 1.210.58Tumour locus central (ref.) vs. peripheral1.350.56 - 3.150.49Surgical approach LNSS (ref.) vs. ONSS1.690.67 - 4.240.26Sex male (ref.) vs. female0.630.24 - 1.670.35Age (years)0.990.95 - 1.040.75BMI (kg/m^2^)0.970.87 - 1.070.50Hypertension no (ref.) vs. yes1.620.66 - 4.000.29Ischaemia time (min)1.010.98 - 1.040.55Operative time (min)1.000.99 - 1.010.86Preoperative ureter stenting no (ref.) vs. yes1.260.41 - 3.860.68Intraoperative blood transfusions no (ref.) vs. yes0.950.08 - 11.050.97Postoperative complications no (ref.) vs. yes0.670.22 - 2.000.47Clavien-Dindo score \< 3 (ref.) vs. ≥ 31.370.22 - 8.410.73Multiple linear regression analysis for models 1 and 2 including ischaemia time as a continuous variable investigating predictors of the relative change (%) of eGFR from baseline at (a) measurement time A (median, 1 day p.o.; IQR, 1--2) and at (b) at measurement time D (median, 13 months p.o.; IQR 12--15), and multiple logistic regression analysis for models 3 and 4 including ischaemia time as a continuous variable investigating (c) predictors for the development of postoperative AKI within 48 h p.o. and (d) predictors for the development of postoperative new-onset CKD stage ≥ 3 (eGFR \< 60 mL/min/1.73 m2) within measurement time DThe regression models are based on pooled estimates from 100 imputed datasets. A *p*-value \< 0.05 is regarded as statistically significant*eGFR* estimated glomerular filtration rate, *CKD* chronic kidney disease, *AKI* acute kidney injury, *LNSS* laparoscopic nephron-sparing surgery, *ONSS* open nephron-sparing surgery, *BMI* body mass index, *OR* odds ratio
